Business● Low3h ago · Nov 4, 2026, 10:01 PM
Vir Biotechnology Non-GAAP EPS of -$0.57 beats by $0.18
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Vir Biotechnology reported Non-GAAP EPS of -$0.57, which exceeded analyst expectations by $0.18. This indicates a better-than-anticipated financial performance for the company despite a negative EPS.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business29m agoWhy Hong Kong wealth managers want broader access to mainland China’s Nasdaq-style marketsSouth China Morning PostBusiness34m agoKennametal projects FY 2027 adjusted EPS of $5-$6 while outlining 16%-19% long-term EBITDA margin targetSeeking Alpha TechBusiness34m agoSmith Douglas expects Q4 closings of 800-875 while targeting 15.5%-16.5% gross marginSeeking Alpha TechBusiness34m agoSinclair forecasts ~$455M full-year 2026 political revenue while lifting adjusted EBITDA to $825M-$835MSeeking Alpha Tech